
|Videos|April 21, 2022
Patient Quality of Life on Lenvatinib plus Pembrolizumab Treatment for Renal Cell Carcinoma
Oncologists review quality of life data for patients with renal cell carcinoma receiving lenvatinib plus pembrolizumab combination treatments.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Belzutifan Combo Improves Disease Control Vs Cabozantinib in Advanced RCC
2
Lymphoma's Revolution: Evens & Rhodes on CLL, CAR-T, and NJ Care
3
Making Nuanced Decisions on CAR-T and Bispecifics in Multiple Myeloma
4
Novel Cancer Vaccine Meets Primary, Secondary End Points in Resected Melanoma
5






























































